Requires long-term care facilities to stock and provide COVID-19 antiviral treatments to residents.

This bill (A 545) requires New Jersey nursing homes and assisted living residences to maintain an on-site supply of COVID-19 antiviral treatments and provide them to residents who test positive for COVID-19 and show symptoms. It directly affects licensed long-term care facilities by mandating immediate stocking and distribution of these treatments. The key provision specifies that facilities must ensure availability and administer antivirals to symptomatic, positive residents without delay. The bill takes effect immediately upon enactment but is currently pending in the Assembly Health Infrastructure Committee.